Laboratory Services Act Decisions

The table below reflects changes associated with laboratory tests in BC. For a list of facility changes, please scroll to the second table.

2017 - Laboratory Test Updates

Laboratory Test, Records of Decision under the Laboratory Services Act

LSA ROD #

Approvals Granted

LSA2017-011

Extension of provisional status for 11 fee for service laboratory medicine fee items.

Effective August 1, 2017, the provisional (P) status of the following 11 fee items is extended to July 31, 2018:

a) 90656 - C. difficile toxin, real time PCR

b) 90751 - Molecular identification, stool isolate

c) 90784 - Trichomonas Antigen Test

d) 90831 - Hepatitis B virus (HBV) identification by nucleic acid amplification, direct – quantification

e) 90832 - BK polyoma virus identification by nucleic acid amplification, direct – quantification

f) 90833 - Cytomegalovirus Viral (CMV) identification by nucleic acid amplification, direct – quantification

g) 91162 - Anti-tissue transglutaminase antibodies (anti-TTG), IgA

h) 91761 - Helicobacter pylori stool antigen (HPSA)

i) 93051 - Cytogenetic analysis/fluorescence in situ hybridization, single probe  

j) 93052 - Cytogenetic analysis/fluorescence in situ hybridization, subtelomeric probe

 k) 93053 - Cytogenetic analysis/fluorescence in situ hybridization (FISH), uncultured amniotic fluid.

LSA2017-025

Removal of neonatal alloimmune thrombocytopenia (NAIT) and hemolytic disease of the fetus and newborn (HDFN) genetic testing on amniotic fluid from the BC Children’s and Women’s Hospital laboratory test menu.

Effective July 1, 2017, the Ministry of Health (MOH) has approved the removal of NAIT and HDFN testing from the BC provincial test menu. Request for testing may be forwarded to the MOH out-of-province/out-of-country program for consideration.

LSA2017-001

Addition of new Provisional (P) fee item P90811 – Gastrointestinal pathogen multiplex panel and selective culture, and amendment to billing rules/notes of existing fee items 90800 – Stool examination, concentration method and 90810 – Stool examination, search for amoebae and/or permanent stain smear to the Laboratory Services Outpatient Payment Schedule. 

Effective July 31, 2017 (amended from June 1, 2017), a new Provisional fee item P90811 Gastrointestinal pathogen multiplex panel (GPMP) and selective culture (SC) was added to the laboratory services outpatient payment schedule. The cost per test was set at $105.04, with the following billing notes: “i) Restricted to Victoria General Hospital Laboratory and Royal Jubilee Hospital Laboratory at Vancouver Island Health Authority (VIHA)” and “ii) For VIHA only, P90811 not payable with: 90630, 90655, P90656, 90725, 90745, 90750 & 90751.” 

Fee item 90800 – Stool examination, concentration methods was amended by adding a new note, it reads “Within Vancouver Island Health Authority, 90800 testing restricted to children under 13 years old, returning travellers, immigrants from outside of Canada and the United States of America, and immunocompromised hosts.”

Fee item 90810 – Stool examination, search for amoebae and/or permanent stain smear was amended by adding a new note, it reads “Within Vancouver Island Health Authority, 90810 testing restricted to children under 13 years old, returning travellers, immigrants from outside of Canada and the United States of America, and immunocompromised hosts.”

LSA2017-022

Amendment of billing notes for fee items 91210 Aspartate aminotransferase (AST) and 91065 Alanine aminotransferase (ALT) 

Effective August 1, 2017, the following billing notes were added to fee items 91210 – Aspartate aminotransferase (AST) and 91065 – Alanine aminotransferase of the laboratory services outpatient payment schedule:

“Note i) Fee item 91065 Alanine aminotransferase (ALT) is the preferred liver function test and is a superior marker of hepatocellular damage compared to the 91210 Aspartate aminotransferase (AST) test” and “Note ii) In addition, measurement of AST 91210 in conjunction with ALT 91065 rarely adds clinical value and should not be co-billed, unless clinically indicated.” 

For fee item 91210 (AST), an additional note was added, it reads:

“Note iii) 91210 AST should only be requested to evaluate liver fibrosis or steatohepatitis.”

LSA2017-007

Addition of new Provisional (P) fee item to the Laboratory Services Outpatient Payment Schedule: fee item P91022 in support of Muscle-specific Tyrosine Kinase Antibody testing.  

Effective June 1, 2017, the Ministry of Health has approved the addition of a new Provisional fee item P91022 Muscle-specific Tyrosine Kinase Antibody testing. Testing will be restricted to UBC Diagnostic Services Laboratory and requires consultation with a Laboratory Medicine physician before test can be requested.

LSA2017-008

Addition of new Provisional (P) fee item to the Laboratory Services Outpatient Payment Schedule: fee item P91861 in support of Voltage-gated Calcium Channel Antibody testing. 

Effective June 1, 2017, the Ministry of Health has approved the addition of a new Provisional fee item P91861 Voltage-gated Calcium Channel Antibody testing. Testing will be restricted to UBC Diagnostic Services Laboratory and requires consultation with a Laboratory Medicine physician before test can be requested.

 

2016 - Laboratory Test Updates

Laboratory Test, Records of Decision under the Laboratory Services Act

LSA ROD #

Approvals Granted

LSA2016-026

Addition of new fee item for Fentanyl, urine screening immunoassay, and amendment to existing Fentanyl confirmatory fee item.

Effective March 1, 2017, the Ministry of Health has approved the addition of a new fee item 92518 Fentanyl, urine screening by immunoassay. The cost per test will be $13.10.   

The Fentanyl confirmatory fee item 92525 was amended by adding a new note to the Laboratory Services Outpatient Payment Schedule that it can only be performed and payable following consultation with and approval by a laboratory medicine physician.

LSA2016-027

Re-costing of B-type natriuretic peptide and addition of the fee item to the primary and split base fee list.

Effective April 1, 2017, the Ministry of Health has amended the fee amount payable for B-type natriuretic peptide (BNP) to $28.14 from $42.56 and made BNP eligible to be co-billed with the primary base fee and split base fees.

LSA2016-018

Establishing non-invasive prenatal testing (NIPT) as an insured benefit in British Columbia

Effective October 9, 2015, NIPT was approved as an insured benefit in British Columbia for pregnant women found to have a significant risk of trisomy by meeting one of the following criteria:

  • Having received a positive prenatal screen for trisomy 18 or 21;
  • Having had previous trisomy 13, 18, or 21 pregnancy;
  • Having a risk of Down Syndrome greater than 1 in 300 based on results of screening and ultrasound marker(s) of aneuploidy; or
  • Having a risk for X-linked disorders identified through the Provincial Medical Genetics program.

LSA2016-031

Request to defer delisting of aspartate aminotransferase (AST) in community outpatient setting.

Effective December 21, 2016, the Ministry of Health is deferring the delisting of aspartate aminotransferase in the community outpatient setting, which was scheduled for February 1, 2017.

LSA2016-021

Request for Cytogenetic Microarray Analysis (CMA) to be funded through fee-for-service.

Cytogenetic Microarray Analysis (CMA) will not be funded on a fee-for-service basis.  

LSA2016-019

Removal of provisional (P) status for Sex Hormone Binding Globulin (SHBG).

Effective September 30, 2016, the P status for fee item 92267 – SHBG was removed.

LSA2016-020

Removal of provisional (P) status for Fecal Immunochemical Test for analysis and Fecal Immunochemical Test for collection.

Effective September 30, 2016, the P status for fee items 92006 and 92007 – FIT was removed.

LSA2016-024

Removal of provisional (P) status for Bile Acids, total – 91241, amendment to the fee amount, and addition of a billing note.

Effective December 1, 2016, the P status for fee item 91241 – Bile Acids, total will be removed, the fee amount will be amended to $36.58 from $55.00, and a billing note will be added that reads “billing restricted to pregnant females only”.

LSA2016-022

Approval of the updated Laboratory Services Payment Schedule - Schedule of Fees

Effective October 1, 2016, the updated Laboratory Services Payment Schedule - Schedule of Fees, was approved.

LSA2016-006

Serum tryptase testing to be repatriated

Serum tryptase testing will no longer be referred out of province. When ready, BC Women’s and Children’s Hospital will provide the testing. Outpatient testing is restricted to physician specialists who are investigating follow-up anaphylaxis, mastocytosis, and mast cell activation disorders. Conversely, inpatient requests are not restricted as testing is almost always clinically indicated.

LSA2016-007

120 inactive outpatient tests to be cancelled, and addition of billing notes

Effective June 30, 2016, 105 Chemistry and 15 Hematology fee-for-service outpatient tests were delisted as they were inactive or had been replaced by other tests. For a complete list of the tests, see attachment “120 tests to be removed from the fee-for-service laboratory outpatient payment schedule.” (PDF, 200KB)

Further, a billing note was added to fee item 91770 (hexosaminidases) that reads “Restricted to BC Children’s Hospital only”.

LSA2016-008

Removal of Provisional (P) status for purine, pyrimidine and creatine disorder (PPCD) screen

Effective June 30, 2016, the P status for fee item P92151 – PPCD screen was removed.

LSA2016-009

Removal of Provisional (P) status for seven antinuclear antibody (ANA) tests, and amendment to billing notes, to allow for provincial wide use of the ANA tests

Effective June 30, 2016, the P status was removed for the following seven fee items:

P90280 Antinuclear antibodies – immunofluorescence screen

P90281 Antinuclear antibodies by sensitive EIA

P90120 Extractable nuclear antigens (ENA)

P90121 Antinuclear antibodies, specific detection by multiplex immunoassay

P90286 Liver autoantibodies (LiAA), immunofluorescence

P90287 Anti-neutrophil cytoplasmic antibodies (ANCA), immunofluorescence screen

P90288 Anti-parietal cell antibody (APCA), immunofluorescence screen

For fee items 90121 and 90281, note ii) was removed, that read

“Restricted to Vancouver Coastal Health Immunology Laboratory”, and replaced with the following

Use ANA/ENA ELISA (90281) as the primary screen; if result of ANA/ENA ELISA (90281) is ≥2U (units), proceed with reflex testing using ENA/DNA multiplex (90121)”

For fee item 90286, the following note was added:

Only one of either 90286 or 90288, not both, are payable for the same sample tested on the same day”

For fee item 90288, note i) was removed, that read

“P90288 (APCA) is not payable with P90286 (LiAA), and was replaced with the following

Only one of either 90286 or 90288, not both, are payable for the same sample tested on the same day”

LSA2016-010

Delist fee item 91210 aspartate aminotransferase (AST)

Effective February 1, 2017, fee item 91210 aspartate aminotransferase (AST) will be delisted. Laboratory operators are to substitute any request for AST with fee item 91065 alanine aminotransferase (ALT)

LSA2016-013

Re-Costing of test 91745 Hemoglobin, A1C, and amendments to billing note

Effective October 1, 2016, the amount for fee item 91745 Hemoglobin, A1C will be changed to $5.30 from $12.69.

Fee item 91745 Hemoglobin A1C will be eligible to be co-billed with the primary base fee (PBF), 91000 or the split base fees 91005 and 91010. Base fees note iv) will be updated in the Laboratory Services Outpatient Payment Schedule to include fee item 91745.

 

2017 Facility Approval Updates - Laboratory & Specimen Collection Stations

Laboratory Facilities Records of Decision under the Laboratory Services Act.

LSA ROD #

Approvals Granted

LSA2017-021

LifeLabs – East Hastings Patient Service Centre

1588 East Hastings Street, Vancouver, BC

Specimen collection station relocation approved.

LSA2017-020

Vancouver Island Health Authority – Kwakiutl District Council Health Care Centre

1400 Drake Road, Campbell River, BC

New specimen collection services approved.

LSA2017-019

Vancouver Island Health Authority – Gold River Health Care Centre

601 Trumpeter Drive, Gold River, BC

New specimen collection services approved.

LSA2017-018

Vancouver Island Health Authority – Bamfield Health Centre

353 Bamfield Road, Bamfield, BC

New specimen collection services approved.

LSA2017-017

Vancouver Island Health Authority – Zeballos Health Centre

500 Parkway Drive, Zeballos, BC

New specimen collection services approved.

LSA2017-016

Vancouver Island Health Authority – Tahsis Health Centre

1085 Maquinna Drive, Tahsis, BC

New specimen collection services approved.

LSA2017-015

Vancouver Island Health Authority – Kyuquot Health Centre

General Delivery, Kyuquot, BC

New specimen collection services approved.

LSA2017-014

Vancouver Island Health Authority – Sayward Primary Healthcare Clinic

601 Kelsey Way, Sayward, BC

New specimen collection services approved.

LSA2017-013

Vancouver Island Health Authority – Sointula Health Centre

25 – 2nd Street, Sointula, BC

New specimen collection services approved.

LSA2017-012

Neurocode Labs Inc. – School of Pharmaceutical Sciences

2405 Wesbrook Mall, Room 5524, Vancouver, BC

New testing only laboratory facility approved.

LSA2017-009

LifeLabs – Yates Patient Service Centre

200 – 1120 Yates Street, Victoria, BC

Approved to relocate their specimen collection station to 200 – 1120 Yates Street, Victoria, BC, from 202 – 1120 Yates Street, Victoria, BC.

LSA2017-006

LifeLabs – Surrey Reference Laboratory

7455 – 130 Street, Surrey, BC

Approved to significantly change capability and capacity.

LSA2017-005

LifeLabs – Peace Arch Patient Services Centre

Approved to relocate their specimen collection station to 120 – 15331 16th Avenue, Surrey, BC, from 120 – 15321 16th Avenue, Surrey, BC.

LSA2017-004

Interior Health Authority – North Hills Mall Primary Care Home

61 – 700 Tranquille Road, Kamloops, BC

New specimen collection station approved.

2016 Facility Approval Updates - Laboratory & Specimen Collection Stations

Laboratory Facilities Records of Decision under the Laboratory Services Act.

LSA ROD #

Approvals Granted

LSA2016-033

LifeLabs - Pacific Autism Family Centre

1001 Hudson Avenue, Richmond, BC

New specimen collection station approved.

LSA2016-032

LifeLabs - Trunk Road Patient Service Centre

103 – 495 Bowen Island Trunk Road, Bowen Island, BC

Specimen collection station relocation approved to 103 - 495 Bowen Island Trunk Road, Bowen Island, BC, from 101 – 469 Bowen Island Trunk Road, Bowen Island, BC.

LSA2016-030

Vancouver Island Health Authority – Royal Jubilee Hospital

23 Helmcken Road, Victoria, BC

Specimen collection station relocation approved to 23 Helmcken Road, Victoria, BC, from 1505 Admirals Road, Victoria, BC.

LSA2016-029

Northern Health Authority – Hudson’s Hope Gething Diagnostic and Treatment Centre

10309 Kyllo Street, Hudson’s Hope, BC

Amendment to an existing laboratory facility Approval to include fee item 90440 - prothrombin time/INR approved.

LSA2016-028

LifeLabs

566 Artisan Lane, Bowen Island, BC

New specimen collection station approved.

LSA2016-025

Novavita Laboratory

Suite 420, East Tower, 555 W 12th Avenue, Vancouver, BC

Moratorium exemption request for a new specimen collection station denied.

LSA2016-023

Interior Health Authority – Tudor Village 

205 – 1150 Hillside Drive, Kamloops, BC

Approved to relocate their specimen collection station to 205 – 1150 Hillside Drive, Kamloops, BC, from 3 – 1315 Summit Drive, Kamloops, BC.

LSA2016-017

Vancouver Island Health Authority - Comox Valley Hospital

307 – 14th Street, Courtenay, BC

New offsite specimen collection services approved.

LSA2016-016

Vancouver Island Health Authority – St. Joseph's General Hospital

2137 Comox Valley Avenue, Comox, BC

Amendment to an existing laboratory facility to provide offsite specimen collection services for Comox Valley Hospital approved.

LSA2016-015

Vancouver Island Health Authority - Comox Valley Hospital - Inpatient

101 Lerwick Road, Comox, BC

Approved to provide necessary laboratory services for admitted inpatient and emergency department patients.

LSA2016-014

Vancouver Island Health Authority – Comox Valley Hospital - Outpatient

101 Lerwick Road, Comox, BC

New onsite laboratory facility and specimen collection station approved. Laboratory services include fee-for-service category 2M, plus microbiology fee items: 90800, 90805, and 90810.

LSA2016-011

LifeLabs - Burnaby Reference Laboratory

2680 Gilmore Way, Burnaby, BC

Approved to transfer chemistry and hematology capacity to Burnaby Reference Laboratory from Surrey Reference Laboratory.

LSA2016-005

LifeLabs - Surrey Reference Laboratory

7455 – 130th Street, Surrey, BC

Approved to amend an existing laboratory facility Approval to include the following three hematology fee-for-service tests: Factor V Leiden/PGM – 1st Gene; Factor V Leiden/PGM – 2nd Gene; and HLA Single Antigen.

LSA2016-004

LifeLabs - Fort Patient Service Centre

230 – 1900 Richmond Road, Victoria, BC

Approved to temporarily relocate their specimen collection station to 230 – 1900 Richmond Road, Victoria, BC, from Suite 130 – 1900 Richmond Road, Victoria, BC.

LSA2016-003

Vancouver Coastal Health Authority – Pemberton Health Centre

1403 Portage Rd, Pemberton, BC

Approved to amend an existing laboratory facility Approval to include 12 fee-for-service tests, and the replacement of amylase with lipase.

LSA2016-002

Vancouver Coastal Health Authority – Whistler Health Care Centre

4380 Lorimer Rd, Whistler, BC

Approved to amend their existing laboratory facility Approval to include Category 2A (Hematology) and 2C (Chemistry).

LSA2016-001

Valley Medical Laboratories

114 - 1835 Gordon Drive, Kelowna, BC

Approved to relocate their specimen collection station to 114 - 1835 Gordon Drive, Kelowna, BC, from 1111 Springfield Road, Kelowna, BC. 

2015 Facility Approval Updates - Laboratory & Specimen Collection Stations

Laboratory Facilities Records of Decision under the Laboratory Services Act

LSA ROD #

Approvals Granted

LSA2015-009

LifeLabs –Reference Laboratory

7455 130th Street, Surrey, BC

Approved to temporarily relocate microbiology testing to the mobile laboratory unit at Surrey Reference Laboratory from the Burnaby Reference Laboratory.